Citations

We’ve gathered published citations for the past many years so that researchers can easily review at their convenience from among the thousands of published articles, how they might use our products in detail or apply these ideas to their own novel thinking for new research.

Search through, read and share our information rich citations below!

Contact us with any questions.

4694 total record number 67 records this year

To narrow your search, use one or more of the following search menus below.

To search by keyword, you may search by the cell/animal/assay/protein/research or publication
Page 415 out of 470
4694 citations found

-Lapachone ameliorization of experimental autoimmune encephalomyelitis

Xu, J;Wagoner, G;Douglas, JC;Drew, PD;

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Product: Pertussis Toxin from B. pertussis, Lyophilized in Buffer

Monitoring oncogenic B-RAF-induced senescence in melanocytes

Tran, SL;Rizos, H;

Product: Cholera Toxin (AZIDE-FREE) from Vibrio cholerae

Recruitment of a myeloid cell subset (CD11b/Gr1 mid) via CCL2/CCR2 promotes the development of colorectal cancer liver metastasis.

Zhao, L;Lim, SY;Gordon-Weeks, AN;Tapmeier, TT;Im, JH;Cao, Y;Beech, J;Allen, D;Smart, S;Muschel, RJ;

Product: Diphtheria Toxin, Unnicked, from Corynebacterium diphtheriae

  • Liver Metastasis Model:

    Tumor cells (5 105/100 L phosphate-buffered saline [PBS]) were injected into the spleens of C57BL/6, CCR2 knockout (KO), severe combined immunodeficiency (SCID), or CD11b-diphtheria toxin receptor (DTR) mice. …CD11b-DTR or C57BL/6 mice received diphtheria toxin (7.5 ng DT/g body weight; List Biological Laboratories)…

Comparison of fluorigenic peptide substrates PL50, SNAPTide, and BoTest A/E for BoNT/A detection and quantification: exosite binding confers high-assay sensitivity.

Ouimet, T;Duquesnoy, S;Poras, H;Fourni-Zaluski, MC;Roques, BP;

Product: SNAPtide® Peptide Substrate (FITC/DABCYL) for C. botulinum Type A Neurotoxin

Neuroanatomical study on the tecto-suprageniculate-dorsal auditory cortex pathway in the rat

Horie, M;Meguro, R;Hoshino, K;Ishida, N;Norita, M;

Product: Cholera Toxin B Subunit (Choleragenoid) from Vibrio cholerae in Low Salt

New 9-aminoacridine derivatives as inhibitors of botulinum neurotoxins and P. falciparum malaria

TOT, M;OPSENICA, DM;MITRIC, M;BURNETT, JC;GOMBA, L;BAVARI, S;OLAJA, BA;

Product: Botulinum Neurotoxin Type B Light Chain, Recombinant

  • In vitro BoNT LC metalloprotease activity:

    Determination of BoNT/A LC percent inhibition by SMNPIs was performed as previously described.  For BoNT/B LC percent inhibition, the HTS-assay utilizes a commercially available fluorogenic substrate from List Biological Laboratories (Campbell, CA). Briefly, a multichannel pipette was used to add fluorescent substrate (final concentration 20 M) and small molecules (final concentration 20 M) to a 96 well microplate. The reactions were initiated by adding recombinant BoNT/B LC (final concentration 40 nM) to each well. All reactions were conducted in a buffered solution consisting of 40 mM Hepes pH 7.2, 1 mM DTT and 100 M ZnCl2. The change in fluorescence intensity over time was continuously monitored in each well using a 96 well plate fluorimeter (Saphire 2, Tecan, Mnnedorf, Switzerland). The assays were run at 37 C, quenched by the addition of TFA, and analyzed using reverse-phase HPLC. Potential SMNPIs of the BoNT B LC were identified by comparing the reaction velocities (change in fluorescence intensity over time) of samples assayed in the presence of compounds versus  control samples.

    Author did not specify which List Biological Laboratories product was utilized.  Refer to the follwing List Labs link for Botulinum products available:  https://listlabs.com/product-information/botulinum-toxins/

Central role for endothelial human deneddylase-1/SENP8 in fine-tuning the vascular inflammatory response

Ehrentraut, SF;Kominsky, DJ;Glover, LE;Campbell, EL;Kelly, CJ;Bowers, BE;Bayless, AJ;Colgan, SP;

Product: LPS from Escherichia coli O55:B5

  • Cell treatments:

    For Western blot experiments and luciferase assays the following treatment regimen was used. Six hours prior to harvesting, cells were treated with 10 mg/ml medium of Escherichia coliderived LPS (E. coli 055:B5; List Biological Laboratories, Campbell, CA), …

    NOTE:  At the time this paper was written, Product #203 (5mg – LPS from Escherichia coli O55:B5) was utilized.

    Product #203 (5 mg – LPS from Escherichia coli O55:B5) is no longer sold.

    Product #203A (2.5 mg – LPS from Escherichia coli O55:B5) is available for purchase.

MicroCor Transdermal Delivery System: A Safe, Efficient, and Convenient Transdermal System for Vaccine Administration

Singh, P;Chen, G;Worsham, W;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis

An adenovirus-vectored nasal vaccine confers rapid and sustained protection against anthrax in a single-dose regimen

Zhang, J;Jex, E;Feng, T;Sivko, GS;Baillie, LW;Goldman, S;Van Kampen, KR;Tang, DC;

Product: Anthrax Protective Antigen (PA), Recombinant from B. anthracis